COVID-19: What EU leaders have mentioned about AstraZeneca vaccine – and knowledge is forcing rethinking | World information

European nations are revising their refusal to provide the aged the Oxford / AstraZeneca COVID-19 vaccine following the discharge of recent knowledge.

The French authorities has made a partial U-turn, with folks aged 65 to 74 with pre-existing well being points now in a position to get the AstraZeneca vaccine.

The vaccine, developed with the College of Oxford, has suffered deployment setbacks and doses languish after almost half of the EUmembers have restricted its use to these below 65.

Comply with COVID-19 updates stay from the UK and around the globe

It has been accredited for all adults by the European medicines regulator, however it’s as much as every member to set their very own coverage, with many saying the preliminary trial didn’t have sufficient efficacy knowledge on these over 65. years.

France’s partial turnaround got here hours after new knowledge launched by Public Well being England (PHE) primarily based on the vaccine’s deployment within the UK confirmed safety towards symptomatic COVID in folks over 70, 4 weeks after the primary vaccine, various between 60-73% and 57-61% for the Pfizer / BioNTech vaccine.

The examine have discovered {that a} dose of both vaccine is over 80% efficient in stopping folks over 80 from being admitted to hospital three to 4 weeks after the primary vaccine.

Sky Information examines which EU nations have restricted the AstraZeneca vaccine.


Emmanuel Macron has been one of the crucial vehement critics of the vaccine, calling it “virtually ineffective” for the aged.

On the finish of January, after ordering 1.1 million doses, Mr Macron mentioned: “The true drawback with AstraZeneca is that it doesn’t work as we anticipated.

“We’re ready for the EMA [European Medicines Agency] outcomes, however immediately every thing means that it’s virtually ineffective on folks over 65 years previous, some say these aged 60 or over. “

French Europe Minister Clément Beaune then mentioned the UK was taking “lots of danger” by having a 12 week hole between the 2 doses and mentioned French residents wouldn’t stand the sort of wager. , though scientists have accredited the tactic. .

Skepticism in the direction of vaccines has been excessive in France for a number of many years, with very low use of the COVID-19 vaccine in comparison with its neighbors and solely 1 / 4 of its AstraZeneca vaccines given on Friday.

In a bid to revive public confidence within the AstraZeneca vaccine, Mr Macron has now mentioned he’ll take it if supplied to him.


The effectiveness of the AstraZeneca vaccine within the aged started to be publicly questioned by European nations after a German newspaper claimed that it was solely 8% efficient in these over 65.

The story of Handelsblatt, on which he was standing, was attributed to a single nameless authorities supply with none rationalization as to how the quantity was calculated.

It occurred within the week that the EMA needed to resolve whether or not or to not authorize the vaccine, which it did on January 29 – albeit with a warning that knowledge for these over 55 was restricted.

German Chancellor Angela Merkel urged to vary stance on AstraZeneca vaccine

Germany then really useful that the vaccine shouldn’t be used for folks over 65, saying there was a scarcity of dependable efficacy knowledge on this age group.

Like France, vaccine deployment in Germany has been a lot slower than within the UK, with vaccines bought being unused.

German officers mentioned one of many primary causes for this low adoption was the age restriction, and a rising variety of distinguished politicians at the moment are calling for the rule to be relaxed, which is anticipated to occur quickly.

European Fee

Ursula von der Leyen, President of the European Fee, has had a really public argument with AstraZeneca over growing her vaccine doses.

She then prompt that the UK had compromised on ‘security and efficacy’ by approving the vaccine so early, regardless of the EMA reaching the identical conclusions because the UK’s internationally famend MHRA which accredited the vaccine.

Please use Chrome browser for a extra accessible video participant

EU chief’s “ regrets ” over vaccine exports

The Fee has been criticized for the gradual tempo of vaccination throughout the bloc, with critics saying it has failed to make sure adequate early provide.

On the finish of February, Ms von der Leyen modified her thoughts as officers rushed to ensure doses weren’t wasted.

“I might take the AstraZeneca vaccine with out considering, identical to the Moderna and BioNTech / Pfizer merchandise,” she advised German newspaper Augsburger Allgemeine.

What different European nations have restricted the AstraZeneca vaccine?

Greece, Denmark, the Netherlands, Sweden (the place AstraZeneca relies with the UK), Poland and Austria have all blocked its use amongst these over 65.

Norway, which isn’t a part of the EU however is a part of the European Financial Space, has additionally blocked its use on these below 65.

Italy initially restricted the jab to these below 55, however on the finish of February they raised it to adults as much as 65.

Belgium and Spain have restricted it to these below 55.

Switzerland, which isn’t a part of the EU however is a part of the only market, rejected AstraZeneca’s jab as a result of it mentioned the take a look at knowledge was “not but adequate”.

Supply hyperlink

Previous Croatia sells 1.3 billion kuna (171.5 million euros) of one-year and six-month treasury payments
Next $ 300 billion quantitative commerce wins in 'virtually unbelievable' market

No Comment

Leave a reply

Your email address will not be published.